Helping adults with intellectual disabilities quit smoking
Adapting and Testing a Smoking Cessation Intervention in Adults with Intellectual and Developmental Disabilities
This study is working on a special program to help adults with intellectual and developmental disabilities quit smoking, by understanding their unique challenges and creating a supportive environment just for them.
Quick facts
| Grant type | Career grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Kentucky NIH-funded |
| Lab location | 1 site (Lexington, United States) |
| Project ID | NIH-10865580 on NIH RePORTER |
What this research studies
This research focuses on developing and testing a smoking cessation program specifically designed for adults with intellectual and developmental disabilities (IDDs). It aims to understand the unique challenges faced by this population in quitting smoking and to adapt existing evidence-based interventions to better meet their needs. By engaging with the community, the research seeks to identify barriers to treatment and create a supportive environment for individuals trying to quit. The ultimate goal is to improve health outcomes for adults with IDDs who smoke.
Who could benefit from this research
Good fit: Ideal candidates for this research are adults aged 21 and older who have intellectual and developmental disabilities and are current smokers.
Not a fit: Patients who do not have intellectual or developmental disabilities or who are not smokers may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to more effective smoking cessation strategies tailored for adults with intellectual disabilities, improving their overall health and quality of life.
How similar studies have performed: While smoking cessation interventions have been successful in the general population, this approach specifically targeting individuals with IDDs is novel and has not been extensively tested.
Where this research is happening
Lexington, United States
- University of Kentucky — Lexington, United States (Active)
Researchers
- Principal investigator: Regnier, Sean — University of Kentucky
- Study coordinator: Regnier, Sean
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.